Slovenia vs Sur: Previously treated cases tested for RR-/MDR-TB
Slovenia
100.0%
in 2024
Sur
62.0%
in 2024
Slovenia rank
1st
Sur rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Slovenia
- Sur
How they compare
Slovenia currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Slovenia's figure about 1.6 times Sur's.
The two have swapped places 2 times across 17 shared years of data; in 2005 it was Slovenia ahead.
Slovenia ranks 1st and Sur ranks 2nd of 180 countries.
Slovenia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Slovenia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.7% | 14.3% | 78.3% | Slovenia |
| 2010s | 89.1% | 53.0% | 36.1% | Slovenia |
| 2020s | 96.6% | 78.4% | 18.2% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Slovenia or Sur?
- Slovenia, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Slovenia and Sur?
- 38.0%, with Slovenia ahead.
- How many years of comparable data are there for Slovenia and Sur?
- 17 years are reported by both, from 2005 to 2024.
- How do Slovenia and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Slovenia ranks 1st and Sur ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.